120 related articles for article (PubMed ID: 1631251)
1. Prolactin responses to domperidone in chronic schizophrenia.
Nerozzi D; Magnani A; Dastoli C; Ferri E; Capesciotti G; Antonozzi I; Frajese G; Meltzer HY
Psychiatry Res; 1992 May; 42(2):159-69. PubMed ID: 1631251
[TBL] [Abstract][Full Text] [Related]
2. Plasma prolactin response to domperidone in acute schizophrenia and schizophreniform illness.
Nerozzi D; Magnani A; Sforza V; Scaramucci E; Cerilli M; Moretti C; Frajese G; Antonozzi I; Meltzer HY
Psychiatry Res; 1990 Nov; 34(2):139-47. PubMed ID: 2149613
[TBL] [Abstract][Full Text] [Related]
3. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.
Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL
Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595
[TBL] [Abstract][Full Text] [Related]
4. Domperidone, an extracerebral inhibitor of dopamine receptors, stimulates thyrotropin and prolactin release in man.
Delitala G; Devilla L; Lotti G
J Clin Endocrinol Metab; 1980 Jun; 50(6):1127-30. PubMed ID: 7372791
[TBL] [Abstract][Full Text] [Related]
5. Seasonal variations in prolactin levels in schizophrenia.
Brown PJ; Cleghorn JM; Brown GM; Kaplan RD; Mitton J; Szechtman H; Szechtman B
Psychiatry Res; 1988 Aug; 25(2):157-62. PubMed ID: 3174903
[TBL] [Abstract][Full Text] [Related]
6. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
[TBL] [Abstract][Full Text] [Related]
7. Effect of domperidone on the release of insulin after intravenous glucose load in man.
Pezzarossa A; Vescovi PP; Cervigni C; Angelini O; Cimicchi MC; Capretti L; Campana G; Butturini U
J Endocrinol Invest; 1986 Oct; 9(5):383-8. PubMed ID: 3540081
[TBL] [Abstract][Full Text] [Related]
8. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.
Newcomer JW; Riney SJ; Vinogradov S; Csernansky JG
Psychiatry Res; 1992 Mar; 41(3):191-202. PubMed ID: 1594706
[TBL] [Abstract][Full Text] [Related]
9. Prolactin and growth hormone responses to growth hormone-releasing hormone in acute schizophrenia.
Nerozzi D; Magnani A; Sforza V; Scaramucci E; Cerilli M; Moretti C; Antonozzi I; Frajese G
Neuropsychobiology; 1990; 23(1):15-7. PubMed ID: 2280826
[TBL] [Abstract][Full Text] [Related]
10. Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteers.
Maes M; Meltzer HY
Psychiatry Res; 1996 Oct; 64(3):147-59. PubMed ID: 8944393
[TBL] [Abstract][Full Text] [Related]
11. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
Sowers JR; Sharp B; McCallum RW
J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
[TBL] [Abstract][Full Text] [Related]
12. Effect of adrenalectomy and dexamethasone treatment on prolactin secretion of lactating rats.
Horváth KM; Bánky Z; Tóth BE; Halász B; Nagy GM
Brain Res Bull; 2001 Dec; 56(6):589-92. PubMed ID: 11786246
[TBL] [Abstract][Full Text] [Related]
13. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.
Keks NA; Copolov DL; Kulkarni J; Mackie B; Singh BS; McGorry P; Rubin RT; Hassett A; McLaughlin M; van Riel R
Biol Psychiatry; 1990 Jun; 27(11):1203-15. PubMed ID: 2354227
[TBL] [Abstract][Full Text] [Related]
14. TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration.
Coiro V; Butturini U; Gnudi A; Volpi R; d'Amato L; Speroni G; Capretti L; Roti E; Chiodera P
Horm Res; 1987; 25(4):206-14. PubMed ID: 3108134
[TBL] [Abstract][Full Text] [Related]
15. The MCPP challenge test in schizophrenia: hormonal and behavioral responses.
Iqbal N; Asnis GM; Wetzler S; Kahn RS; Kay SR; van Praag HM
Biol Psychiatry; 1991 Oct; 30(8):770-8. PubMed ID: 1751620
[TBL] [Abstract][Full Text] [Related]
16. Prolactin response to submaximal stimulation by TRH in nonaffective psychoses.
Spoov J; Bredbacka PE; Appelberg B; Katila H; Karonen SL; Rimón R; Sarna S
Biol Psychiatry; 1991 Feb; 29(3):204-10. PubMed ID: 1673063
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
Abel KM; O'Keane V; Murray RM
Br J Psychiatry; 1996 Jan; 168(1):57-60. PubMed ID: 8770429
[TBL] [Abstract][Full Text] [Related]
18. Differential TSH and PRL responses to dopamine receptor blockade in acromegaly.
Prescott RW; Weightman DR; Kendall-Taylor P; Johnston DG
Clin Endocrinol (Oxf); 1984 Oct; 21(4):369-75. PubMed ID: 6509782
[TBL] [Abstract][Full Text] [Related]
19. An abnormal relation between basal prolactin levels and prolactin response to 12.5 microg TRH i.v. in drug-naïve patients with first-episode schizophrenia.
Spoov J; Bredbacka PE; Stenman UH
Schizophr Res; 2010 Jun; 119(1-3):41-6. PubMed ID: 20347273
[TBL] [Abstract][Full Text] [Related]
20. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]